Viewing StudyNCT06439771



Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06439771
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-21
First Post: 2024-05-16

Brief Title: A Phase 2 Study to Evaluate the Efficacy Safety and Pharmacokinetics of YL202 in Patients With BC
Sponsor: MediLink Therapeutics Suzhou Co Ltd
Organization: MediLink Therapeutics Suzhou Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04-23
Start Date Type: ACTUAL
Primary Completion Date: 2026-07-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-07-29
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-16
First Submit QC Date: May 27 2024
Study First Post Date: 2024-06-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-19
Last Update Post Date: 2024-06-21
Last Update Post Date Type: ACTUAL